HOX Gene
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes (NCT06229912) | M.D. Anderson Cancer Center | 2024-06-04 |
Track HOX Gene automatically
Every clearance here is in the API, with alerts when new ones post.